FM
MRNA icon

Foster & Motley’s Moderna MRNA Stock Holding History

Foster & Motley’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,417
Closed -$434K – 389
2022
Q4 		$434K Sell
2,417
-2,122
-47% -$347K 0.04% 290
2022
Q3 		$537K Buy
4,539
+1,456
+47% +$221K 0.05% 246
2022
Q2 		$440K Sell
3,083
-4,713
-60% -$674K 0.04% 267
2022
Q1 		$1.34M Buy
7,796
+4,053
+108% +$682K 0.11% 166
2021
Q4 		$951K Buy
+3,743
New +$1.09M 0.07% 192

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Foster & Motley's MRNA Position: Q1 2023 in Review

Foster & Motley sold out of Moderna (MRNA) in Q1 2023, closing a stake of 2,417 shares — an estimated $434K sold.

Foster & Motley first reported a position in MRNA in Q4 2021 and held it in 5 quarters. The position peaked at $1.34M in Q1 2022. 1,015 funds tracked by Wall St. Rank hold MRNA as of Q1 2023.

  • Foster & Motley reported no remaining Moderna position as of Q1 2023 after selling out during the quarter.
  • Foster & Motley sold 2,417 Moderna shares in Q1 2023, an estimated $434K.
  • Foster & Motley first reported a position in Moderna in Q4 2021 and held it in 5 quarters.
  • Foster & Motley's Moderna position peaked at $1.34M in Q1 2022.
  • 1,015 funds tracked by Wall St. Rank held Moderna as of Q1 2023.

Based on Foster & Motley's 13F filing for Q1 2023, filed 9 May 2023.